Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional Profile 

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

  • It Is Not All about Alkaloids—Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.3390/plants13162208

  • Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
    Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2024
    DOI: 10.1002/cbdv.202400159

  • Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
    Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. Mailänder, Iris Klaiber, Sven Nicolay, Manuel Garcia-Käufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
    Year: 2023
    DOI: 10.3390/fermentation9020190

  • Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
    Authors: Lilo K. Mailänder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
    Year: 2022
    DOI: 10.3390/molecules27238508

  • Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
    Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/plants10061219

  • Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
    Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
    Year: 2021
    DOI: 10.3390/pr9050853

  • Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
    Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2021
    DOI: 10.3390/molecules26061530

  • Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000485

  • Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
    Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
    Year: 2020
    DOI: 10.1002/cbdv.202000788

 

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Posted on by ScienceFather

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short

Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Posted on by ScienceFather

Dr. Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Reader at Usmanu Danfodiyo University, Sokoto , Nigeria (Academia).

Dr. Chinenye Jane Ugwah-Oguejiofor is a Nigerian pharmacologist and toxicologist with over two decades of academic and research experience. She holds a PhD in Pharmacology from the University of Nigeria and is currently a Reader at Usmanu Danfodiyo University, Sokoto. Her research focuses on natural products, particularly Caralluma dalzielii, with studies addressing public health issues such as fertility, cervical cancer, malaria, and snakebites. She has published extensively in peer-reviewed journals, showcasing her contributions to pharmacological science. Dr. Ugwah-Oguejiofor’s work also includes computational drug discovery, examining bioactive compounds for potential therapeutic applications. Her academic journey reflects a deep commitment to education, mentorship, and advancing pharmaceutical research. While her work is regionally impactful, expanding international collaborations and exploring patent opportunities could further enhance her global research profile. Overall, Dr. Ugwah-Oguejiofor is a dedicated and influential figure in her field.

Profile:

Education

Dr. Chinenye Jane Ugwah-Oguejiofor’s education reflects a strong foundation in pharmacology and related fields. She earned her Bachelor of Pharmacy (B. Pharm.) degree in 2001 from the University of Nigeria, Nsukka, followed by a Master of Science (M.Sc.) in Pharmacology from Usmanu Danfodiyo University, Sokoto in 2011. Her academic pursuit culminated in 2018 when she received her PhD in Pharmacology from the University of Nigeria. Additionally, she completed a diploma in computer studies in 2003 from Rima Computer Training Institute, Sokoto, which adds a valuable dimension to her research skills, particularly in bioinformatics and computational drug discovery. This robust academic background, spanning undergraduate to doctoral studies, has equipped her with the knowledge and skills to make significant contributions to pharmacological research. Dr. Ugwah-Oguejiofor’s educational achievements underpin her extensive research work in natural products and toxicology, positioning her as a prominent figure in the field of pharmaceutical sciences.

Professional Experience

Dr. Chinenye Jane Ugwah-Oguejiofor has a rich professional experience in pharmacology and academia, spanning over two decades. She began her career as an intern pharmacist at Ebonyi State University Teaching Hospital (2001-2002), followed by a year as a National Youth Service Corps (NYSC) pharmacist at Usmanu Danfodiyo University Teaching Hospital. She then served as a Superintendent Pharmacist in various pharmacies, gaining practical expertise in the field. In 2008, Dr. Ugwah-Oguejiofor transitioned into academia as an Assistant Lecturer in the Department of Pharmacology and Toxicology at Usmanu Danfodiyo University. She steadily rose through the ranks, becoming a Senior Lecturer by 2019 and a Reader in 2022. Throughout her career, she has conducted significant research in pharmacology, focusing on natural products and toxicology, while mentoring students and contributing to curriculum development. Her professional journey highlights a blend of clinical practice and academic excellence, with a strong emphasis on research and education.

Research Skills

Dr. Chinenye Jane Ugwah-Oguejiofor possesses a diverse set of research skills honed through her extensive work in pharmacology and toxicology. Her expertise lies in natural product research, particularly focusing on the pharmacological properties of medicinal plants like Caralluma dalzielii. She has a strong command of both in vivo and in vitro experimental methodologies, demonstrated by her studies on fertility, cancer, malaria, and antimicrobial activities in animal models. Additionally, her proficiency in bioinformatics and cheminformatics is evident in her computational drug discovery projects, where she explores the molecular mechanisms of bioactive compounds using docking and pharmacophore modeling. Dr. Ugwah-Oguejiofor’s research also extends to toxicity assessments, evaluating the safety of plant extracts in various biological systems. Her ability to integrate traditional pharmacology with modern computational tools enhances the depth of her research. Her strong publication record in peer-reviewed journals further underscores her skills in data analysis, scientific writing, and collaborative research.

Award and Recognition

Dr. Chinenye Jane Ugwah-Oguejiofor has garnered recognition for her contributions to pharmacology and toxicology, particularly through her impactful research on natural products. While specific awards and honors have not been detailed, her academic promotions, including her rise to the position of Reader at Usmanu Danfodiyo University, reflect her recognition within the academic community. Her extensive publication record in high-impact, peer-reviewed journals such as Drug and Chemical Toxicology and Journal of Ethnopharmacology also demonstrates her research’s value and her standing in the scientific community. Dr. Ugwah-Oguejiofor’s work on key public health challenges like cancer, malaria, and fertility issues in the African context has likely contributed to her growing reputation. She has been involved in several collaborative research projects, both nationally and internationally, further validating her expertise. Although formal awards are not mentioned, her academic achievements and consistent research output are testament to her recognition as a leading figure in her field.

Conclusion

Dr. Chinenye Jane Ugwah-Oguejiofor is a highly competent and productive researcher whose work addresses critical health issues, particularly within the context of pharmacology and toxicology. Her extensive publication record, focus on indigenous medicinal plants, and long-standing academic career make her a strong candidate for the Best Researcher Award. However, to further strengthen her candidacy, she could benefit from expanding international collaborations, securing more research grants, and pursuing innovation through patents.

Publication Top Notes

  1. Acute and sub-acute toxicity of aqueous extract of aerial parts of Caralluma dalzielii NE Brown in mice and rats
    • Authors: C.J. Ugwah-Oguejiofor, C.O. Okoli, M.O. Ugwah, M.L. Umaru, C.S. Ogbulie, …
    • Year: 2019
    • Citations: 131
  2. A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19
    • Authors: T.O. Johnson, A.E. Adegboyega, O.A. Ojo, A.J. Yusuf, O. Iwaloye, …
    • Year: 2022
    • Citations: 40
  3. Comparative studies of anti-ulcerogenic activities of three Nigerian medicinal plants: a preliminary evaluation
    • Authors: M.O. Ugwah, E.U. Etuk, S.O. Bello, A.A. Aliero, C.J. Ugwah-Oguejiofor
    • Year: 2013
    • Citations: 34
  4. Ethno botanical studies of medicinal plants used in the management of Peptic ulcer disease in Sokoto State, North Western Nigeria
    • Authors: A.C. Oluranti, U.O. Michael, U.O.C. Jane, N.A. Ayembe
    • Year: 2012
    • Citations: 30
  5. Evaluation of the antiulcer activity of the aqueous stem bark extract of Balanites aegyptiaca L Delile in Wistar rats
    • Authors: M.O. Ugwah, C.J. Ugwah-Oguejiofor, E.U. Etuk, S.O. Bello, A.A. Aliero
    • Year: 2019
    • Citations: 28
  6. Evaluation of the antinociceptive and anti-inflammatory effect of Caralluma dalzielii
    • Authors: C.J. Ugwah-Oguejiofor, K. Abubakar, M.O. Ugwah, A.A. Njan
    • Year: 2013
    • Citations: 27
  7. Ficus platyphylla promotes fertility in female Rattus norvegicus Wistar strain: a preliminary study
    • Authors: C.J. Ugwah-Oguejiofor, S.O. Bello, R.U. Okolo, E.U. Etuk, M.O. Ugwah, …
    • Year: 2011
    • Citations: 25
  8. Drug utilization pattern in pregnancy in a tertiary hospital in Sokoto, North West
    • Authors: K. Abubakar, R. Abdulkadir, S.B. Abubakar, A.O. Jimoh, …
    • Year: 2014
    • Citations: 24
  9. Antioxidant and antikindling effect of Tapinanthus globiferus growing on Ficus glumosa in pentylenetetrazole induced kindled rats
    • Authors: K. Abubakar, A.T. Yunus, M.R. Abubakar, J.C. Ugwah-Oguejiofor, …
    • Year: 2018
    • Citations: 20
  10. Phytochemical screening and anticonvulsant activity of the residual aqueous fraction of Tapinanthus globiferus growing on Ficus glumosa
    • Authors: K. Abubakar, I.M. Adebisi, J.C. Ugwah-Oguejiofor, G.O. Idris, B. Idris, …
    • Year: 2016
    • Citations: 20
  11. Antidiarrhoeal activity of the saponin and flavonoid fractions of Anarcadium occidentale leaves in albino rats
    • Authors: K. Abubakar, M.R. Abubakar, J.C. Ugwah-Oguejiofor, A.A. Muhammad, …
    • Citations: Not available

 

 

 

Jean de Dieu Baziki | Monoclonal Antibodies | Best Innovation Award

Posted on by ScienceFather

🌟Dr. Jean de Dieu Baziki , Monoclonal Antibodies, Best Researcher Award🏆

 Doctorate at AU-PANVAC, Ethiopia

Jean de Dieu BAZIKI, Ph.D., IFBA, is a Rwandese national currently serving as a Laboratory Assistant and Training Coordinator at the Pan African Veterinary Vaccine Centre of the African Union Commission (AU/PANVAC) in Ethiopia. With a background in Molecular Biology & Biotechnology, Baziki has extensive experience in quality management systems, biosecurity management, and the development of disease diagnostic kits. He is dedicated to enhancing laboratory capabilities across Africa through training, capacity building, and the adoption of advanced technologies.

Author Metrics:

Scopus Profile

ORCID Profile

Jean de Dieu BAZIKI has contributed significantly to the scientific community through his publications in reputable journals. His work focuses on infectious diseases in animals, particularly in the development and evaluation of diagnostic tools and vaccines. Baziki’s research has garnered attention for its impact on disease control and surveillance efforts in Africa.

  • Citations: 38 citations by 36 documents
  • Documents: 5
  • h-index: 3

Education:

Baziki holds a Ph.D. in Molecular Biology & Biotechnology from the Pan African University/Jomo Kenyatta University of Agriculture and Technology (PAU/JKUAT) in Kenya. He also obtained an MSc in Microbiology from Periyar University, India, and an Advanced Diploma in Biomedical Lab Sciences from Kigali Health Institute, Rwanda. His educational background equips him with the knowledge and skills necessary for his role in advancing veterinary science and biotechnology.

Research Focus:

Jean de Dieu BAZIKI’s research primarily focuses on infectious diseases affecting animals, with a specialization in the development and validation of diagnostic assays and vaccines. He is particularly interested in diseases such as Contagious Caprine Pleuropneumonia (CCPP), Peste des Petits Ruminants (PPR), and other transboundary animal diseases prevalent in Africa. Baziki’s work aims to improve disease detection, control, and prevention strategies to safeguard animal health and enhance food security.

Professional Journey:

Baziki’s professional journey spans over a decade, during which he has held various positions in laboratory management, research, and training. He began his career as a Clinical Supervisor and Laboratory Technician at the Diagnostic Laboratory Center of Kigali Health Institute, Rwanda. Since 2009, he has been serving at AU/PANVAC in Ethiopia, where he has played a key role in implementing quality management systems, conducting research, and providing training to laboratory scientists across Africa.

Honors & Awards:

Throughout his career, Jean de Dieu BAZIKI has received recognition for his contributions to veterinary science and biotechnology. His dedication to advancing laboratory capabilities and promoting biosecurity has earned him several honors and awards, including certifications from the International Federation of Biosafety Associations (IFBA) and recognition for his research publications in esteemed scientific journals.

Publications Noted & Contributions:

Baziki has made significant contributions to the field of veterinary science through his publications in reputable journals. His research on the development and evaluation of diagnostic assays and vaccines for infectious diseases in animals has been noted for its impact on disease control and surveillance efforts in Africa. Baziki’s work has advanced our understanding of disease dynamics and has contributed to the development of effective control strategies.

Title: “Evaluation of Ppr Monoclonal Antibodies In Immunofluorescence For Rapid Quality Control of Peste Des Petits Ruminants (Ppr) Vaccine”

  • Journal: Small Ruminant Research
  • Year: 2022
  • DOI: 10.1016/j.smallrumres.2022.106865
  • Contributors: Dr. Jean de Dieu Baziki; Habeeb Ayinde Oyedele; Charles S. Bodjo; Hassane Diallo; Hassan Belay Gelaw; Ethel Chitsungo; Cisse Rahamatou Moustapha Boukary; Hiwot Fikru; Gbolahanmi Akinola Oladosu, et al.

Title: “South-to-south mentoring as a vehicle for implementing sustainable health security in Africa”

  • Journal: One Health Outlook
  • Year: 2021
  • DOI: 10.1186/s42522-021-00050-x
  • Contributors: Stephanie Marie Norlock; Patrick W. Okanya; Anastasia Trataris; Michael E. Hildebrand; Jean de Dieu Baziki; Imane Belkourati; Maureen Ellis

Title: “Corrigendum to “Development and Evaluation of an Immuno-Capture Enzyme-Linked Immunosorbent Assay to Quantify the Mycoplasma capricolum subsp. Capripneumoniae (Mccp) Protein in Contagious Caprine Pleuropneumonia (CCPP) Vaccine””

  • Journal: Veterinary Medicine International
  • Year: 2021
  • DOI: 10.1155/2021/9813273
  • Contributors: Jean de Dieu Baziki; Charles Bodjo S.; Nick Nwankpa; Naomi Maina; Ethel Chitsungo; Cisse Rahamatou Moustapha Boukary; Takele A. Tefera; Rume Veronica Nwankpa; Nduta Mwangi

Title: “Sero-epidemiology of peste des petits ruminants in Oromia and Afar regional states of Ethiopia”

Title: “Development and Evaluation of an Immuno-Capture Enzyme-Linked Immunosorbent Assay to Quantify the Mycoplasma capricolum subsp. capripneumoniae (Mccp) Protein in Contagious Caprine Pleuropneumonia (CCPP) Vaccine”

  • Journal: Veterinary Medicine International
  • Year: 2020
  • DOI: 10.1155/2020/4236807
  • Contributors: Jean de Dieu Baziki; Bodjo S. Charles; Nick Nwankpa; Naomi Maina; Ethel Chitsungo; Cisse Rahamatou Moustapha Boukary; Takele A. Tefera; Rume Veronica Nwankpa; Nduta Mwangi

Research Timeline:

Baziki’s research journey has been marked by a series of milestones and achievements. Beginning with his educational pursuits in Molecular Biology & Biotechnology and Microbiology, he has progressively focused his research efforts on infectious diseases in animals. His doctoral studies provided a platform for in-depth research on disease diagnostics and vaccine development, which he continues to pursue in his current role at AU/PANVAC.

Collaborations and Projects:

Jean de Dieu BAZIKI has been actively involved in collaborative projects aimed at addressing key challenges in veterinary science and biotechnology. He has participated in workshops, training sessions, and research initiatives organized by international organizations, governments, and research institutions. These collaborations have facilitated knowledge exchange, capacity building, and the development of innovative solutions to combat infectious diseases in animals across Africa.

Guohai Zhang | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

🌟Dr. Guohai Zhang, Medicinal Chemistry, Young Scientist Award🏆

Doctorate at Guangxi Normal University, China

Guo-Hai Zhang is an Associate Professor at the State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University. His research primarily focuses on targeted therapy and drug resistance mechanisms in lung cancer. He has made significant contributions to understanding the role of wild-type EGFR and p53 in non-small cell lung cancer (NSCLC), as well as the molecular basis of p53 mitochondrial localization. Guo-Hai Zhang has conducted numerous research projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC, resulting in 20 SCI papers published in reputable journals.

Author Metrics

Scopus Profile

Guo-Hai Zhang has authored or co-authored 20 SCI papers published in journals such as J Med Chem, J Biol Chem, Biochem Pharmacol, and Eur J Med Chem. These publications demonstrate his impact and recognition in the field of lung cancer research, particularly in understanding targeted therapy and drug resistance mechanisms.

Citations: 566 citations by 514 documents

Documents: 27

h-index: 14

Education

Guo-Hai Zhang pursued his Ph.D. in the medical field at Nanjing University. Prior to that, he obtained a Master’s degree from Huaqiao University and a Bachelor’s degree from Shandong University of Science and Technology, both focusing on molecular medicine and chemistry.

Research Focus

Guo-Hai Zhang’s research primarily focuses on targeted therapy and drug resistance mechanisms in lung cancer, particularly non-small cell lung cancer (NSCLC). His work includes elucidating the role of wild-type EGFR and p53 in NSCLC, understanding the molecular mechanisms underlying drug resistance, and exploring intervention methods to overcome resistance.

Professional Journey

Guo-Hai Zhang’s professional journey began as a Research Associate at the State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, where he conducted research from 2011 to 2017. Since December 2017, he has held the position of Associate Professor at the same institution, continuing his research in targeted therapy and drug resistance mechanisms in lung cancer.

Honors & Awards

Guo-Hai Zhang’s contributions to the field of lung cancer research have earned him recognition and honors, although specific awards and honors are not mentioned in the provided information.

Publications Noted & Contributions

Guo-Hai Zhang has made notable contributions to the field of lung cancer research through his publications. Some of his key contributions include elucidating the role of wild-type EGFR and p53 in NSCLC, understanding the molecular mechanisms of drug resistance, and exploring intervention methods to overcome resistance. His research findings have been published in reputable journals such as J Med Chem, J Biol Chem, Biochem Pharmacol, and Eur J Med Chem.

Title: Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation
Authors: Li, L., Du, W., Wang, H., …, Zeng, S., Zhang, G.
Journal: Chemico-Biological Interactions, 2022, 366, 110142
Citations: 1

Title: Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation
Authors: Li, L., Li, P., Ma, X., …, Peng, Y., Zhang, G.
Journal: Biochemical Pharmacology, 2022, 203, 115188
Citations: 3

Title: Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment
Authors: Zhang, D., Zhao, Y., Wang, L., …, He, S., Li, E.
Journal: American Journal of Respiratory Cell and Molecular Biology, 2022, 67(2), pp. 227–240
Citations: 1

Title: Targeting entry into mitochondria for increased anticancer efficacy of BCL-XL-selective inhibitors in lung cancer
Authors: Li, L., Li, P., Song, H., …, Peng, Y., Zhang, G.
Journal: Pharmacological Research, 2022, 177, 106095
Citations: 2

Title: Glycyrrhizic acid inhibits SARS-CoV-2 infection by blocking spike protein-mediated cell attachment
Authors: Li, J., Xu, D., Wang, L., …, Li, E., He, S.
Journal: Molecules, 2021, 26(20), 6090
Citations: 32

Research Timeline

Guo-Hai Zhang’s research timeline spans from his tenure as a Research Associate from 2011 to 2017 to his current position as an Associate Professor, which he has held since December 2017. Throughout this time, he has been actively involved in conducting research projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC.

Collaborations and Projects

Guo-Hai Zhang has collaborated on various research projects focused on targeted therapy and drug resistance mechanisms in lung cancer. His research group has conducted projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC, contributing to the understanding of lung cancer biology and the development of targeted therapies.